Stock 1302 LIFETECH SCIENTIFIC CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News LifeTech Scientific Corporation

Equities

1302

KYG548721177

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 EDT 		5-day change 1st Jan Change
1.69 HKD +0.60% Intraday chart for LifeTech Scientific Corporation +6.29% -28.09%
04-11 Lifetech Scientific Buys Shares For Employee Incentive Scheme MT
04-04 Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lifetech Scientific Buys Shares For Employee Incentive Scheme
MT
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits
MT
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
PR
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
MT
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
LifeTech Scientific Flags Significant Profit Drop in 2023
MT
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
LifeTech Scientific to Grant 174.8 Million Share Options
MT
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter
MT
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
PR
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue
MT
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
CI
China Grants Official Registration Approval for LifeTech Scientific's Surgical Navigation System
MT
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA
CI
Jenscare Scientific, LifeTech Complete Treatment for Valve Replacement Product; Jenscare Shares Rise 3%
MT
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo
MT
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System
MT
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
CI
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
CI
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1302 Stock
  4. News LifeTech Scientific Corporation